Published in Gene Therapy Weekly, February 14th, 2002
NautCell has been developed by Nautilus using its proprietary high-throughput platform biomics technology for cell-directed evolution, after more than 40,000 individual rAAV viral infections with rAAV produced by cell clones obtained from the Microbix' 293 HEK cell line.
NautCell displays a stable 1-2 logs higher productivity for rAAV compared with the parental 293 HEK cells, and is designed to meet the rapidly growing rAAV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.